Publications by authors named "Ingrid Diagne"

Claim this Profile
[
[Zanidatamab in second line setting of advanced HER2-positive biliary tract cancers].
Ingrid Diagne, Matthieu Delaye

Bull Cancerยท December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis